Pharmaceutical Regulatory Affairs: Open Access

ISSN: 2167-7689

Open Access

Karungamye Pazos

Department of Neurology, Wan Fang Hospital, Taipei Medical University, Taipei 116, Taiwan

  • Mini Review   
    Pharmacological Remedies for Traumatic Brain Injury at Present and in Future
    Author(s): Ali Dhama* and Karungamye Pazos

    The current article explored the pharmacologic treatments of traumatic brain injury (TBI), including current and likely medicines. Pharmacologic treatments are a fundamental piece of TBI care, and a few specialists have deep rooted impacts in TBI care. In the intense stage, tranexamic corrosive, antiepileptics, hyperosmolar specialists, and sedatives are the pillar of pharmacotherapy, which have demonstrated efficacies. In the post-intense stage, SSRIs, SNRIs, antipsychotics, zolpidem and amantadine, as well as different medications, have been utilized to oversee neuropsychological issues, while muscle relaxants and botulinum poison have been utilized to oversee spasticity. What's more, expanding quantities of pre-clinical and clinical investigations of drug specialists, including likely neuroprotective supplements and regular treatments, are being done. In the.. Read More»
    DOI: 10.37421/2167-7689.2022.11.36

    Abstract HTML PDF

50+ Million Readerbase

Journal Highlights

Google Scholar citation report
Citations: 400

Pharmaceutical Regulatory Affairs: Open Access received 400 citations as per Google Scholar report

Pharmaceutical Regulatory Affairs: Open Access peer review process verified at publons

Indexed In

arrow_upward arrow_upward